Treatment & models of care
COPD
Investigating the roles, therapeutic targeting and clinical relevance of microRNAs in COPD.
Each year, research into lung disease enhances our knowledge to support advances in diagnosis, treatment and hopefully one day – the prevention and cure of lung diseases.
Since 1990, Lung Foundation Australia has raised and invested $15.6 million into a number of research projects. A snapshot of recent and current projects includes:
- Developing the National Standards for Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) to ensure best practice delivery of this exercise and education program.
- Immune regulation of Idiopathic Pulmonary Fibrosis (IPF) to support early diagnosis of the disease and the identification of new targeted therapies.
- Deep profiling of lung cancer, metastasis and the immune system to identify new therapeutic targets and support early diagnosis that will enable more people to have curative surgery.
- Molecular profiling of tumours to identify specific characteristics associated with lung cancer.
- The impact of childhood respiratory infection, bronchitis and asthma in the development of reduced lung function / COPD in middle age.
- Benefits of home based pulmonary rehabilitation in COPD.
- Anxiety and depression in IPF, and the impact on long term outcomes.
- Facilitation of clinical trials that contribute to new advances in the diagnosis, treatment and management of lung cancer.
Why should I support research?
When you make a donation or bequest to lung disease research, you are supporting work towards an increased understanding of lung disease, what causes it, how it can be prevented and how it should be treated.
